Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Aurinia Pharmaceuticals Inc. (AUPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Aurinia Appoints Two New Board Directors with Deep Experience in BioPharma Leadership, Commercial Strategy, Mergers and Acquisitions and Advancing Therapeutic Pipelines Dr. Karen Smith and Jeffrey A. Bailey joined Aurinia’s Board of Directors August 18, 2023"
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "AURINIA PHARMACEUTICALS REPORTS SECOND QUARTER AND SIX MONTHS 2023 FINANCIAL AND OPERATIONAL RESULTS"
07/06/2023 PX14A6G Form PX14A6G - Notice of exempt solicitation submitted by non-management:
07/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Aurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Value In Addition, Board has Accepted Recent Director Resignations and has Initiated a Search for New Directors"
06/01/2023 PX14A6G Form PX14A6G - Notice of exempt solicitation submitted by non-management:
05/26/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/11/2023 PX14A6G Form PX14A6G - Notice of exempt solicitation submitted by non-management:
05/10/2023 SC 13D/A ILJIN SNT Co., Ltd. reports a 5% stake in Aurinia Pharmaceuticals Inc.
05/08/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/05/2023 PX14A6G Form PX14A6G - Notice of exempt solicitation submitted by non-management:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
05/03/2023 PX14A6G Form PX14A6G - Notice of exempt solicitation submitted by non-management:
05/02/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023 PX14A6G Form PX14A6G - Notice of exempt solicitation submitted by non-management:
04/18/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/05/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Aurinia Pharmaceuticals Announces Promising Topline Data from Renal Biopsy Sub-study of the AURORA Trial",
"Renal Biopsy Sub-study April 2023"
03/13/2023 8-K Other Events  Interactive Data
02/28/2023 10-K Annual Report for the period ended December 31, 2022
02/28/2023 8-K Quarterly results
Docs: "AURINIA REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS AND COMPANY UPDATES"
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/07/2023 SC 13G BlackRock Inc. reports a 5.7% stake in Aurinia Pharmaceuticals Inc
01/27/2023 8-K Other Events  Interactive Data
01/20/2023 SC 13D/A ILJIN SNT Co., Ltd. reports a 5.1% stake in Aurinia Pharmaceuticals Inc.
01/09/2023 8-K Results of Operations and Financial Condition  Interactive Data
Docs: "AURINIA PROVIDES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL-YEAR 2022 NET REVENUE RESULTS"
01/06/2023 SC 13D/A ILJIN SNT Co., Ltd. reports a 5.1% stake in Aurinia Pharmaceuticals Inc.
01/03/2023 8-K Other Events  Interactive Data
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 8-K Quarterly results
10/28/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/21/2022 8-K Quarterly results
09/19/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy